Autoimmune pancreatitis: a case report
DOI:
https://doi.org/10.23938/S1137-6627/2016000100018Keywords:
"Autoimmune pancreatitis", "IgG4-related disease"Abstract
Autoimmune pancreatitis (AIP) is an infrequent pathology, although there is a growing incidence in Eastern countries, which might be due to a greater rate of detection. It can be associated with other autoimmune pathologies and its association with IgG4-related systemic disease has been described. Its clinical presentation is varied and the normal treatment is medical, using corticoids.
A diagnosed clinical case is described.
Key words. Autoimmune pancreatitis. IgG4.
Downloads
References
1. Okazaki K. Autoimmune pancreatitis is increasing in Japan. Gastroenterology 2003; 125: 1557-1558.
https://doi.org/10.1016/j.gastro.2003.09.011
2. Kamisawa T, Egawa N, Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003; 98: 2811-2812.
https://doi.org/10.1111/j.1572-0241.2003.08758.x
3. Raina A, Yadav D, Krasinskas AM, McGrath KM, Khalid A, Sanders M et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol 2009; 104: 2295-2306.
https://doi.org/10.1038/ajg.2009.325
4. Frulloni L, Scattolini C, Falconi M, Zamboni G, Capelli P, Manfredi R et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol 2009; 104: 2288-2294.
https://doi.org/10.1038/ajg.2009.327
5. Sahani DV, Kalva SP, Farrell J, Maher MM, Saini S, Mueller PR et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233: 345-352.
https://doi.org/10.1148/radiol.2332031436
6. Sandanayake NS, Church NI, Chapman MH, Johnson GJ, Dhar DK, Amin Z et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7: 1089-1096.
https://doi.org/10.1016/j.cgh.2009.03.021
7. Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009; 7: 1097-1103.
https://doi.org/10.1016/j.cgh.2009.04.020
8. Buijs J, Cohen DL, Van Heerde MJ, Rauws E, De Buy Wenniger LM, Hansen BE et al. Long-term relapse rates of type 1 and type 2 autoimmune pancreatitis. Gastroenterology 2014; 146 Suppl 1: S-804.
https://doi.org/10.1016/S0016-5085(14)62908-5
9. Maire F, Rebours V, Vullierme MP, Couvelard A, Lévy P, Hentic O et al. Does tobacco influence the natural history of autoimmune pancreatitis? Pancreatology 2014; 14: 284-288.
https://doi.org/10.1016/j.pan.2014.05.793
10. Buijs J, Cahen DL, van Heerde MJ, Rauws EA, de Buy Wenninger LJ, Hansen BE et al.. The long-term impact of autoimmune pancreatitis on pancreatic function, quality of life and live expectancy. Pancreas 2015; 44: 1065-1071.
https://doi.org/10.1097/MPA.0000000000000451
11. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M et al. International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology. Pancreas 2011 ; 40 : 352-358.
https://doi.org/10.1097/MPA.0b013e3182142fd2
12. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebig RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013; 62: 1607-1615.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
